CVS Financial News

Rite Aid plans to close about 7% of its stores initially, as the drugstore chain makes its way through its Chapter 11 bankruptcy process

Sona BLW Precision Forgings, an automotive technology company, witnessed a strong spike in its shares on Thursday after the company posted the highest-ever revenue, EBITDA, and net profit for the September quarter. The company on Wednesday posted a 34% YoY and 15.7% QoQ growth in its consolidated net profit at ₹124 crore, while the revenue from operations came in at ₹791 crore, an increase of 20% YoY, and it reported an EBITDA of ₹223 crore for Q2 FY24, an improvement of 35% YoY and 28.2% QoQ. Following the robust Q2FY24 performance, the stock began Thursday's trade positively, opening at ₹520 apiece, 1.41% higher than the previous closing price of ₹512.75, and zoomed further during the trade to hit an intraday high of ₹539.95 apiece, up by 5.30%.

CVS Health is pulling from its drugstore shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers

Amazon will soon make prescription drugs fall from the sky when the e-commerce giant becomes the latest company to test drone deliveries

Customers may need a dose of patience at U.S. pharmacy counters as those businesses start their busiest season

Maruti Suzuki, Hero MotoCorp, Tata Motors, Bajaj Auto fell anywhere between 1% to 3%. Decline in auto stocks dragged Nifty Auto index over 1% lower. The index was also the top sectoral loser on NSE.

The increasing number of job seekers reflects their concerns about the GST’s potential effects on their future. Experts from over half-a-dozen staffing firms told ET that this trend has become particularly pronounced in recent weeks.

A group of pharmacists frustrated with overwhelming workloads didn't show up for work last week in at least a dozen Kansas City-area CVS pharmacies

HWL Ebsworth says it has emerged largely unscathed from the cybercrime attack that stole 2.5 million files this year, and that its profitability remains “well above industry average”.

The shift in responsibility for Covid-19 shot distribution from federal agencies to the commercial market is off to a rocky start. People eager to get updated Covid-19 vaccines are having their appointments canceled or encountering confusion over insurance coverage. CVS said some appointments were rescheduled because of delivery delays.

Shibani Sircar Kurian, Senior EVP, Fund Manager & Head -Equity Research, Kotak Mahindra AMC, says focus will be towards the slightly larger PSU banks given their ability to defend market share as well as their ability to raise capital which will again help in terms of loan growth as well as deposit growth. The auto pack is fairly well placed. There are pockets where growth remains strong, margins are improving because lower commodity costs continue to play out and in terms of portfolio positioning in the auto and auto ancillaries space, Kotak continues to be overweight. Let us begin with PSU banking space itself because that seems to be the flavour right now. Which are the names, if any, that still look very good? Will you stick your neck out and talk about only the largecap PSU banking names or is it getting a lot wider?While I cannot talk about specific names, let us discuss the PSU banking pack as a whole. Over the last year or so, there has been tailwinds in the overall banking sector and there has been improvement in terms of profitability in terms of return on assets for the bank. The second most important factor is that we are now in a scenario where credit costs have been extremely benign and then together with the news that has come in today in terms of the bond inclusion, overall it does look that from interest rate perspective and bond yield perspective, there is the much needed downside support that has come through.

West Virginia Attorney General Patrick Morrisey ® discusses the lifting of Title 42 and the Biden administration's handling of the border and opioid crises.

Hackers stole 2.5 million documents from HWL Ebsworth clients in April and published about 1 million on the dark web in June, with some victims yet to be notified that their information has been compromised, the national cybersecurity coordinator has revealed.

Check out the companies making headlines before the bell:

Investing.com — Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: an Overweight initiation for Super Micro Computer, and upgrades for Dell, CVS, Globus Medical , and Rackspace Technology.

Varun Saboo, Head, Equities, Anand Rathi Shares, says: “we are very positive right now on autos and particularly not only autos, but the discretionary space overall. If you see, there is a rising trend and everyone is trying to upgrade. I have personally met most of the auto companies recently in the last couple of weeks. What I am gathering is that there is a big surge in terms of what people are wanting in terms of premiumisation. My biggest bet right now is two-wheelers, very positive on all three, Bajaj Auto, TVS and Hero MotoCorp. These three are the top ideas there, which I would like. ”Which are your favourite defence stocks and what are the house views on defence as a pack?I do not, as such, have official coverage of defence names. But yes, if one has to ask my opinion, I think the better names would be HAL, Hindustan Aeronautics or BEL for that matter.

Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for Tesla, CVS, ImmunoGen, and Etsy, and a downgrade for DoorDash.

(Reuters) -The U.S. Food and Drug Administration on Tuesday warned eight companies, including pharmacy giants CVS Health Corp (NYSE:CVS) and Walgreens Boots Alliance (NASDAQ:WBA), against manufacturing or marketing unapproved ophthalmic drug products.

Investing.com — Here is your Pro Recap of the biggest analyst picks you may have missed since Friday: upgrades at CVS Health, Brown Forman, Geron, and a buy initiation for Block.

The cancer drug Gleevec went generic in 2016 and can be bought today for as little as $55 a month. But many patients’ insurance plans are paying more than 100 times that. CVS Health and Cigna can charge $6,600 a month or more for Gleevec prescriptions, a Wall Street Journal analysis of pricing data found.

auto stocks, whose fortunes will be aligned with the performance of the companies during this period, have come under the spotlight. Top brokerages along with analysts that ETMarkets spoke to remain gung ho on the prospects of the sector. A look at the Nifty Auto index’s performance over the past one year suggests that it has done better than Nifty50 and also outperformed Nifty IT, Nifty Bank, Nifty FMCG, Nifty Metal and Nifty Media during this period while underperforming Nifty Pharma and Nifty Realty. https://datawrapper.dwcdn.net/fER2n/2/" scrolling=«no» frameborder=«0» style=«border: none;» width=«600» height=«478» data-external=«1»> Kranthi Bathini, Director-Equity Strategy at WealthMills Securities opines that the outperformance of the auto sector will likely continue going ahead in the wake of the upcoming festive season. The strength in the economy, disposable income and the growing preference for big cars will see the auto industry sail comfortably through the season, Bathini said. The auto sales have been strong on a year-on-year and quarter-on-quarter basis with traction for sports utility vehicles (SUVs) growing among vehicle buyers, he said, while highlighting that the future is EVs (electric vehicles) and India is witnessing a transformational shift towards them. The WealthMills Securities Director remains bullish on Tata Motors, Mahindra & Mahindra and Maruti Suzuki among the OEMs while he is betting on Minda Corporation and Samvardhana Motherson International among the ancillaries.